Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/2160
Título : Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli.
Autor : Retamar, Pilar
López-Cerero, Lorena
Muniain, Miguel Angel
Pascual, Álvaro
Rodríguez-Baño, Jesús
Filiación: [Retamar,P; López-Cerero,L; Muniain,MA; Pascual,A; Rodríguez-Baño,J] Unidad Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, Spain. [Muniain,MA; Rodríguez-Baño,J] Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain. [Pascual,A] Departamento de Microbiología, Universidad de Sevilla, Sevilla, Spain.
Grupo de Investigación: ESBL-REIPI/GEIH Group
Palabras clave : Antibacterianos
Estudios de cohortes
Quimioterapia combinada
Infecciones por escherichia coli
Pruebas de sensibilidad microbiana
Ácido senicilánico
Infecciones urinarias
MeSH: Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents
Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Bacteremia
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Cohort Studies
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors
Medical Subject Headings::Organisms::Bacteria::Proteobacteria::Gammaproteobacteria::Enterobacteriaceae::Escherichia::Escherichia coli
Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Enterobacteriaceae Infections::Escherichia coli Infections
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Microbiological Techniques::Microbial Sensitivity Tests
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Penicillins::Penicillanic Acid
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Amides::Lactams::beta-Lactams::Penicillins::Penicillin G::Ampicillin::Piperacillin
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome
Medical Subject Headings::Diseases::Bacterial Infections and Mycoses::Infection::Urinary Tract Infections
Medical Subject Headings::Chemicals and Drugs::Enzymes and Coenzymes::Enzymes::Hydrolases::Amidohydrolases::beta-Lactamases
Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Aged
Fecha de publicación : Jul-2013
Editorial : American Society for Microbiology
Cita Bibliográfica: Retamar P, López-Cerero L, Muniain MA, Pascual Á, Rodríguez-Baño J, Gijón P, et al. Impact of the MIC of piperacillin-tazobactam on the outcome of patients with bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli. Antimicrob. Agents Chemother. 2013; 57(7):3402-4
Abstract: We investigated the impact of the piperacillin-tazobactam MIC in the outcome of 39 bloodstream infections due to extended-spectrum-β-lactamase-producing Escherichia coli. All 11 patients with urinary tract infections survived, irrespective of the MIC. For other sources, 30-day mortality was lower for isolates with a MIC of ≤ 2 mg/liter than for isolates with a higher MIC (0% versus 41.1%; P = 0.02).
Descripción : Journal Article; Research Support, Non-U.S. Gov't;
URI: http://hdl.handle.net/10668/2160
Versión del editor : http://aac.asm.org/content/57/7/3402.abstract
DOI: 10.1128/AAC.00135-13
ISSN : 1098-6596 (Online)
0066-4804 (Print)
Appears in Collections:01- Artículos - Hospital Virgen Macarena

Files in This Item:
File Description SizeFormat 
Retamar_ImpactMICPiperacillin-Tazobactam.pdfArtículo publicado321,56 kBAdobe PDFView/Open
Retamar_ImpactMICPiperacillin_so1.pdftablas14,87 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons